Meiji Seika Pharma Co., Ltd.
16
2
2
13
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 16 trials
100.0%
+13.5% vs industry average
38%
6 trials in Phase 3/4
31%
4 of 13 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
Role: collaborator
A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
Role: collaborator
P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales
Role: lead
Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in Subjects With Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis
Role: lead
Long-term Extension Trial of Asenapine in Subjects With Schizophrenia (Study P06125)
Role: collaborator
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
Role: lead
Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque Psoriasis
Role: collaborator
Arbekacin Treatment of Adult Patients With Infections Caused by Multidrug-resistant Bacteria
Role: collaborator
A Phase 3 Study of Fluvoxamine (SME3110) in Pediatric/Adolescent Patients With Obsessive Compulsive Disorder
Role: collaborator
A Phase 1 Pharmacokinetic Bioequivalence Study of DMB-3113 and Adalimumab in Healthy Japanese Adult Male Subjects
Role: lead
A Study to Assess the Pharmacokinetic Profile, the Safety, and the Tolerability of ME1100 Inhalation Solution in Patients With Mechanically Ventilated Bacterial Pneumonia
Role: lead
Bioequivalence Study Evaluating the Pharmacokinetics of DMB-3111 and Trastuzumab in Healthy Japanese Male Adults
Role: lead
A Phase I Study to Assess Safety, Tolerability and Pharmacokinetics of OP0595
Role: lead
Intrapulmonary Pharmacokinetics of ME1100 in Healthy Volunteers
Role: lead
Pharmacokinetics and Safety Study of ME1100 in Healthy Volunteers
Role: lead
Pharmacokinetics and Safety Study of ME1111 in Moderate to Severe Onychomycosis Patients
Role: lead
All 16 trials loaded